Effects of LPA and S1P on the Nervous System and Implications for Their Involvement in Disease

E-ISSN： 1873-5592|8|1|155-167

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.1, 2007-01, pp. : 155-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of S1P on Myoblastic Cell Contraction: Possible Involvement of Ca²⁺-Independent Mechanisms

Cells Tissues Organs, Vol. 178, Iss. 3, 2005-01 ,pp. : 129-138

Karger

Access to resources Recommend Favorite

The Glutamatergic System and Alzheimers Disease: Therapeutic Implications

By Butterfield D.A. Pocernich C.B.

CNS Drugs, Vol. 17, Iss. 9, 2003-01 ,pp. : 641-652

Adis International

Access to resources Recommend Favorite

Remarkably long-lasting tachyphylaxis of pain responses to ET-1: evidence against central nervous system involvement

By Khodorova Alla Strichartz Gary R.

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 6, 2010-06 ,pp. : 668-675

NRC Research Press

Access to resources Recommend Favorite

Trafficking and Signaling of G Protein-Coupled Receptors in the Nervous System: Implications for Disease and Therapy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 539-556

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Epigenetics in Nervous System Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 1, 2013-02 ,pp. : 126-141

Bentham Science Publishers

Access to resources Recommend Favorite